Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
VAY736 + Ibrutinib for Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 1
La Jolla, California
This trial is for people with CLL who are receiving ibrutinib, and are either unresponsive or have developed resistance mutations. The goal is to find the maximum tolerated dose of VAY736 in combination with ibrutinib.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.